DPP4 and atrial fibrillation: DPP-4 inhibition contributes to atrial remodeling and improves mitochondrial function, thereby reducing the risk of atrial fibrillation which predisposes to cerebrovascular events (Chang et al., 2017; Nakai et al., 2022).